Free Stock & ETF Comparisons

Compare Amazon's global scale and AWS profit engine against MercadoLibre's e-commerce, fintech (Mercado Pago), and logistics dominance across Latin America.

Compare Amazon's diversified logistics and retail empire against DoorDash's food and local delivery focus, including Amazon's own delivery ambitions as a competitive threat.

Compare Amazon's worldwide logistics network against Coupang's dominant same-day delivery model in South Korea and its expansion into Taiwan.

Compare Amazon's broad retail and cloud business against Wayfair's furniture-focused model, its history of thin margins, and path to sustainable profitability.

Compare Amazon's owned-and-operated Whole Foods/Fresh grocery push against Instacart's asset-light marketplace model connecting retailers to shoppers.

Compare Amazon's massive scale advantages against Chewy's pet-category focus, subscription Autoship revenue, and customer loyalty in a niche Amazon also competes in.

Compare NVIDIA's AI accelerator dominance against Micron's HBM memory business, a critical and increasingly capacity-constrained input for every AI GPU NVIDIA ships.

Compare NVIDIA's explosive AI-driven growth and premium valuation against Texas Instruments' steady, cyclical analog and embedded chip business with a long dividend history.

Compare NVIDIA's dominant merchant GPU franchise against Marvell's custom AI chip (ASIC) partnerships with hyperscalers looking to reduce NVIDIA dependence.

Compare Broadcom's custom AI accelerator and networking chip business against Micron's cyclical but AI-critical HBM and DRAM memory franchise.

Compare Broadcom's profitable, diversified AI networking and software business against Intel's capital-intensive foundry turnaround and lagging AI chip position.

Compare Micron's HBM-driven memory upcycle against Texas Instruments' more stable, less cyclical analog and embedded processing business.

Compare Micron's HBM and DRAM memory exposure to AI data centers against Marvell's custom silicon and optical networking chips for the same buildout.

Compare AMD's MI300-series AI GPU push against NVIDIA against Texas Instruments' cyclical but cash-generative analog and embedded chip franchise.

Compare Intel's costly foundry buildout and process-node turnaround against Texas Instruments' proven, lower-risk analog chip manufacturing model.

Compare Intel's x86 CPU business and foundry ambitions against Marvell's faster-growing custom AI silicon and data center networking chips.

Compare Intel's struggling CPU and foundry business against Qualcomm's dominant mobile chipset franchise, licensing royalties, and push into PC and automotive chips.

Compare Texas Instruments' mature, high-margin analog chip business against Marvell's faster-growing but more cyclical custom AI and networking silicon.

Compare ASML's irreplaceable monopoly on extreme ultraviolet lithography machines against Teradyne's chip and robotics testing equipment business.

Compare ASML's must-have EUV lithography tools against Entegris' specialty materials, filtration, and contamination-control products used across chip fabs.

Compare ASML's dominant lithography franchise against Onto Innovation's smaller but growing process control and inspection equipment business for advanced chip nodes.

Compare Lam Research's dominant etch and deposition tools against Teradyne's automated test equipment for chips and industrial robotics.

Compare Lam Research's etch and deposition equipment franchise against Entegris' materials and filtration products consumed throughout the chipmaking process.

Compare Lam Research's scale in etch and deposition tools against Onto Innovation's more specialized process control and metrology equipment.

Compare Applied Materials' broad wafer fabrication equipment portfolio against Teradyne's focused automated test equipment and robotics business.

Compare SpaceX's reusable rocket and Starlink dominance against GE Aerospace's commercial jet engine franchise (LEAP, GE9X) and its aftermarket services cash flow.

Compare SpaceX's rocket launch and Starlink businesses against Howmet Aerospace's fasteners, forgings, and engine components used across the entire aerospace supply chain, including SpaceX's own suppliers.

Compare SpaceX's launch, satellite internet, and Starship ambitions against General Dynamics' submarines, combat vehicles, and Gulfstream business jets.

Compare GE Aerospace's commercial engine and aftermarket services franchise against Lockheed Martin's F-35 program and broader defense contracting business.

Compare GE Aerospace's engine manufacturing and services business against Howmet Aerospace's fasteners and forgings that GE itself depends on.

Compare GE Aerospace's commercial jet engine aftermarket economics against General Dynamics' defense, marine, and Gulfstream business jet segments.

Compare GE Aerospace's high-margin commercial jet engine services business against Northrop Grumman's defense electronics, space systems, and B-21 bomber program.

Compare RTX's Pratt & Whitney engines, Collins Aerospace, and Raytheon defense segments against Howmet Aerospace's fasteners and forgings supply chain role.

Compare JPMorgan's scale across investment banking, trading, and consumer banking against TD Bank's Canadian retail dominance and US East Coast branch network, still recovering from its anti-money-laundering settlement.

Compare JPMorgan's diversified US banking scale against UBS's global wealth management franchise, still integrating the Credit Suisse acquisition.

Compare JPMorgan's dominant US banking franchise against Bank of Montreal's push into US commercial banking following its Bank of the West acquisition.

Compare Bank of America's massive US consumer deposit base against TD Bank's combined Canadian and US East Coast retail banking footprint.

Compare Bank of America's consumer and commercial banking scale against UBS's global private banking and wealth management franchise.

Compare Bank of America's national US footprint against Bank of Montreal's expanding US commercial banking presence.

Compare Wells Fargo's recovery since the Federal Reserve lifted its asset cap against TD Bank's Canadian and US retail banking franchise.

Compare Citigroup's multi-year restructuring and simplification effort against UBS's global wealth management scale post-Credit Suisse integration.

Compare Eli Lilly's Zepbound/Mounjaro-driven growth against Johnson & Johnson's broader, more diversified pharmaceutical and medtech portfolio.

Compare Eli Lilly's weight-loss and diabetes drug dominance against AstraZeneca's oncology and rare disease pipeline and international revenue mix.

Compare Eli Lilly's premium-valued GLP-1 franchise against Gilead's steady HIV treatment cash flows and expanding oncology and liver disease pipeline.

Compare Eli Lilly's premium valuation on GLP-1 growth against Pfizer's lower multiple, higher dividend yield, and post-pandemic revenue reset.

Compare Johnson & Johnson's broad pharmaceutical and medtech business against AstraZeneca's oncology-heavy pipeline and stronger international exposure.

Compare Johnson & Johnson's broad-based pharma and medtech portfolio against Amgen's biosimilar franchise and early-stage obesity drug pipeline (MariTide).

Compare Johnson & Johnson's diversified drug and medtech portfolio against Gilead's concentrated HIV treatment dominance and growing oncology business.